Litigation Details for POTTER v. VALEANT PHARMACEUTICALS INTERNATIONAL, INC. (D.N.J. 2015)

POTTER v. VALEANT PHARMACEUTICALS INTERNATIONAL, INC. (D.N.J. 2015)

Docket		Date Filed	2015-10-22
Court	District Court, D. New Jersey	Date Terminated	2019-09-10
Cause	15:78m(a) Securities Exchange Act	Assigned To	Michael Andre Shipp
Jury Demand	Both	Referred To	Lois H. Goodman
Parties	T. ROWE PRICE BLUE CHIP GROWTH TRUST
Patents	6,861,053; 7,045,620; 7,326,711; 7,452,857; 7,605,240; 7,612,199; 7,902,206; 7,906,542; 7,915,275; 8,158,644; 8,158,781; 8,193,196; 8,309,569; 8,518,949; 8,642,573; 8,741,904; 8,829,017; 8,835,452; 8,853,231; 8,946,252; 8,969,398
Attorneys	KATE ELIZABETH JANUKOWICZ
Firms	Midlige Richter LLC
Link to Docket	External link to docket

Biologic Drugs cited in POTTER v. VALEANT PHARMACEUTICALS INTERNATIONAL, INC.

Details for POTTER v. VALEANT PHARMACEUTICALS INTERNATIONAL, INC. (D.N.J. 2015)

Date Filed	Document No.	Description	Snippet	Link To Document
2016-09-13	167	Exhibit 31-48	Patent No. 6,861,053 (the “‘053 patent”), U.S. Patent No. 7,452,857 (the “‘857 patent”), U.S. Patent No. 7,…620 patent, the ‘199 patent, the ‘206 patent, the ‘542 patent, the ‘275 patent, the ‘644 patent, the…of the ‘569 patent, the ‘573 patent, the ‘017 patent, the ‘252 patent and the ‘398 patent. Alfa Wassermann…the ‘781 patent, the ‘196 patent, the ‘949 patent, the ‘904 patent, the ‘452 patent and the ‘231 patent…of the ‘053 patent, the ‘857 patent, the ‘240 patent, the ‘608 patent and the ‘799 patent , each of which	External link to document
2020-04-22	539	Exhibit Seeger Decl Ex. H - Class Cert Brief	.86 $93.88 $93.91 7,326,711 1.74% 12/9/2015 $94.40 …Allergan PLC was challenging the patent to a key drug, and then saw Moody's put it	External link to document